Free Cash Flow
Cash generated after capital expenditures.
Latest Free Cash Flow: $1.47B (2026Q1); -60.0% YoY; -2.1% CAGR since 2011Q1 (15y).
Chart and table show the latest 24 of 61 quarters.
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Rule of 40
Quarterly Free Cash Flow Data
Chart and table show the latest 24 of 61 quarters.
| Period | Value |
|---|---|
| 2020Q2 | $2.86B |
| 2020Q3 | $7.66B |
| 2020Q4 | $7.22B |
| 2021Q1 | $4.00B |
| 2021Q2 | $4.55B |
| 2021Q3 | $7.55B |
| 2021Q4 | $4.36B |
| 2022Q1 | $3.62B |
| 2022Q2 | $4.78B |
| 2022Q3 | $5.34B |
| 2022Q4 | $3.98B |
| 2023Q1 | $2.43B |
| 2023Q2 | $3.13B |
| 2023Q3 | $6.64B |
| 2023Q4 | $6.39B |
| 2024Q1 | $3.06B |
| 2024Q2 | $5.02B |
| 2024Q3 | $7.01B |
| 2024Q4 | $5.42B |
| 2025Q1 | $3.66B |
| 2025Q2 | $2.89B |
| 2025Q3 | $8.09B |
| 2025Q4 | $5.47B |
| 2026Q1 | $1.47B |
Healthcare Comparison
1 / 3
Other JNJ Charts
More quarter-by-quarter fundamentals for Johnson & Johnson
1 / 8